IMMVENTION THERAPEUTIX
IMMvention Therapeutix is a biotechnology company developing novel small molecule pan-inflammasome inhibitors for treating inflammatory diseases. It has a platform technology where it harnesses the immune system via biodegradable biopolymeric nano/micro-particles. The company's expertise targets auto-inflammatory ailments for which there are large unmet wants, together with rheumatoid arthritis, osteoarthritis, gout, and Alzheimer’s illness. Its illness-modifying therapies inhibit irritation attributable to inflammasomes that activate inflammatory responses. The corporate makes use of its platform to find small-molecule inhibitors of a number of inflammatory receptors.
IMMVENTION THERAPEUTIX
Industry:
Biotechnology Health Care Therapeutics
Founded:
2017-01-01
Address:
Chapel Hill, North Carolina, United States
Country:
United States
Website Url:
http://www.immventionthera.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
7.15 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Microsoft Exchange Online Office 365 Mail GoDaddy DNS
Current Employees Featured
Founder
Investors List
North Carolina Biotechnology Center
North Carolina Biotechnology Center investment in Debt Financing - IMMvention Therapeutix
Official Site Inspections
http://www.immventionthera.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "IMMvention Therapeutix"
Bach1 | IMMvention Therapeutix
IMMvention Therapeutix works on first-in-class Bach1 inhibitors with transformative potential as oral therapy for patients with sickle cell disease (SCD) and beyond.See details»
IMMvention Therapeutix - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 919-593-6230 IMMvention Therapeutix is a biotechnology company developing novel small molecule pan-inflammasome inhibitors for …See details»
Team - IMMvention
Discover the talented individuals behind our success on our Team Page. Learn more about our dedicated professionals, their expertise, and how they contribute to delivering exceptional service. Our team is committed to excellence and …See details»
IMMvention Therapeutix, Inc. - LinkedIn
IMMvention Therapeutix, Inc. | 634 followers on LinkedIn. Interventions for Human Diseases | Venture-funded company, discovering and developing oral novel small molecule first-in-class inhibitors ...See details»
News & Events | IMMvention - immventionthera.com
For more information, please visit: www.immventionthera.com. About Novo Nordisk Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our …See details»
IMMvention Therapeutix, Inc. - SignalHire
Organization Website: immventionthera.com : Social Links: IMMvention Therapeut... industries Biotech: Headquarters Location: 5 Laboratory Dr, Durham, North Carolina, 27709 US 5 …See details»
IMMvention Therapeutix, Inc. - Drug pipelines, Patents ... - Patsnap
Www.immventionthera.com. Startups | Holding Company | 2017 | North Carolina, United States | < 10 | www.immventionthera.com. Last update 07 Mar 2025. Overview. Pipeline. Deal. ... The …See details»
IMMvention Therapeutix Inc. - VentureRadar
"Discovering and developing novel small molecule pan-inflammasome inhibitors for treating inflammatory diseases. "First-in-class", pan-inflammasome small molecule inhibitors for more …See details»
Immvention Therapeutix - Overview, News & Similar companies
Immvention Therapeutix contact info: Phone number: (919) 593-6230 Website: www.immventionthera.com What does Immvention Therapeutix do? IMMvention was founded …See details»
IMMvention Therapeutix, Inc. - edgein.io
Stealth-mode venture-funded company. Discovering and developing oral novel small molecule inhibitors for treating neurodegenerative and cardiometabolic diseases.See details»
IMMvention Therapeutix, Inc. | Innovate Carolina
Immune Interventions for Human Diseases IMMvention Therapeutix, co-founded at UNC-Chapel Hill by Dr. Jenny Ting, is focused on improving the lives of patients with rare and prevalent …See details»
IMMvention Therapeutix - Products, Competitors, Financials, …
IMMvention Therapeutix operates as a venture-funded company in the healthcare and pharmaceutical industry. Use the CB Insights Platform to explore IMMvention Therapeutix's …See details»
IMMvention Therapeutix Enters Strategic Collaboration with Novo …
Jan 22, 2025 For more information, please visit: www.immventionthera.com. About Novo Nordisk Novo Nordisk is a leading global healthcare company, founded in 1923 and …See details»
Approach & Pipeline | Immvention Therapeutix
IMMvention's mission is to create a globally accessible therapy, benefiting patients with limited or no access to gene therapies. Currently in preclinical stage, IMM-4800 has exceptional drug …See details»
IMMvention Therapeutix - PitchBook
IMMvention Therapeutix General Information Description. Developer of small molecule pan-inflammasome inhibitors designed to improve clinical outcomes and transformative potential in …See details»
IMMvention Therapeutix Inc. - VentureRadar
Website: http://www.immventionthera.com. Discovering and developing novel small molecule pan-inflammasome inhibitors for treating inflammatory diseases.See details»
IMMvention Therapeutix Inc. | North Carolina Biotech Center
IMMvention develops small molecule therapies that inhibit multiple inflammasome receptors to treat both rare and prevalent inflammatory diseases.See details»
IMMvention Therapeutix, Inc. (IMMvention Therapeutix, Inc.) - 药 …
了解IMMvention Therapeutix, Inc. (IMMvention Therapeutix, Inc.)公司的药物管线，治疗领域，技术平台，以及它的，疾病领域:神经系统疾病，血液及淋巴系统疾病，内分泌与代谢疾病，技 …See details»
IMMvention Therapeutix | CipherBio
Explore IMMvention Therapeutix's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
IMMvention Therapeutix Enters Strategic Collaboration with
DURHAM, N.C., Jan. 22, 2025 (GLOBE NEWSWIRE) -- IMMvention Therapeutix, Inc., an early-stage biotechnology company focused on discovering and developing human therapeutics, …See details»